Viemed Healthcare, Inc.
VMD
$6.92
$0.324.85%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 14.72% | 16.87% | 19.62% | 17.41% | 26.91% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 14.72% | 16.87% | 19.62% | 17.41% | 26.91% |
| Cost of Revenue | 19.26% | 24.33% | 31.83% | 25.44% | 28.29% |
| Gross Profit | 11.67% | 11.67% | 12.54% | 12.46% | 25.99% |
| SG&A Expenses | 11.43% | 17.28% | 17.11% | 13.80% | 27.17% |
| Depreciation & Amortization | -6.37% | -16.14% | -20.97% | -16.95% | 26.51% |
| Other Operating Expenses | 78.64% | -188.46% | -438.46% | -573.17% | -16,750.00% |
| Total Operating Expenses | 15.31% | 19.77% | 22.65% | 18.09% | 26.30% |
| Operating Income | 7.63% | -38.35% | -4.68% | 10.94% | 34.70% |
| Income Before Tax | 121.07% | 72.65% | 24.21% | 29.72% | -26.59% |
| Income Tax Expenses | 123.05% | 83.78% | 17.64% | 20.76% | 5.49% |
| Earnings from Continuing Operations | 120.04% | 69.06% | 27.24% | 33.78% | -36.61% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -933.33% | -- | -- | -- | -- |
| Net Income | 115.05% | 63.76% | 24.13% | 32.85% | -37.00% |
| EBIT | 7.63% | -38.35% | -4.68% | 10.94% | 34.70% |
| EBITDA | 8.59% | -7.27% | 1.59% | 8.87% | 26.24% |
| EPS Basic | 111.38% | 60.87% | 22.48% | 31.49% | -37.83% |
| Normalized Basic EPS | 48.01% | -50.13% | -8.09% | 5.37% | -15.20% |
| EPS Diluted | 111.38% | 50.00% | 35.79% | 42.57% | -37.00% |
| Normalized Diluted EPS | 48.73% | -50.27% | -9.32% | 5.51% | -13.75% |
| Average Basic Shares Outstanding | 1.78% | 1.83% | 1.39% | 1.13% | 1.30% |
| Average Diluted Shares Outstanding | 1.31% | 2.58% | 2.82% | 0.89% | -0.30% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |